FRBA vs CARE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

FRBA

66.8
AI Score
VS
FRBA Wins

CARE

66.6
AI Score

Investment Advisor Scores

FRBA

67score
Recommendation
HOLD

CARE

67score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric FRBA CARE Winner
Forward P/E 8.3403 13.6612 FRBA
PEG Ratio 0 0 Tie
Revenue Growth 1.7% 68.3% CARE
Earnings Growth 5.1% 253.9% CARE
Tradestie Score 66.8/100 66.6/100 FRBA
Profit Margin 31.7% 44.9% CARE
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

FRBA 1M: -1.1% · 3M: +1.2% CARE 1M: -2.7% · 3M: -7.3%

Current Technical Phase

FRBA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.5 · Price: $17.73

CARE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.9 · Price: $30.76

Fundamentals Snapshot

Metric FRBA CARE
Market Cap — —
Forward P/E 9.7 11.7
Trailing P/E 10.1 5.2
Revenue (TTM) — —
Revenue Growth 0.0% 0.7%
Gross Margin 1.0% 1.0%
Operating Margin 0.4% 0.6%
EPS 1.71 5.80
Dividend Yield 0.02% 0.00%

Frequently Asked Questions

Based on our detailed analysis, FRBA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.